External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Roche and Genentech at

AAIC 2022

July 31 - August 04

San Diego, USA / Virtual (Hybrid)

aaic.alz.org

Add to calendar

Medical Materials

Agenda

Coming soon

02:15 PM

Duration 10mins San Diego Convention Center, Ballroom 20BC

Using an external control to contextualize efficacy data from patients with prodromal and mild Alzheimer’s disease treated with gantenerumab in SCarlet RoAD and Marguerite RoAD open-label extension studies

Delmar P, Huang Z, Neve A, Klein G, Kerchner GA, Fontoura P, Baudler M, Doody RS

Neuroscience | Alzheimer Disease

Add to calendar

11:15 AM

Duration 10mins Virtual

Selecting appropriate meaningful change thresholds for trials of early (prodromal-to-mild) AD: A caregiver-rated, anchor-based analysis based on the Tauriel Study

Claire Landsall

Neuroscience | Alzheimer Disease

Add to calendar

08:00 AM

Duration 45mins San Diego Convention Center, Ballroom 20D

The clinical development history of gantenerumab, a subcutaneous anti-Aβ monoclonal antibody for early Alzheimer’s disease: Building on lessons from the past and paving a path for the future

Randall J. Bateman, MD, Janice Smith, PhD, Nick C. Fox, MD, Sandra E. Black, MD, FRCPC, Jiong Shi, MD, Raymond Scott Turner, MD, PhD, Rachelle S. Doody, MD, PhD

Neuroscience | Alzheimer Disease

Add to calendar

Follow us here

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.